Sysmex (OTCMKTS:SSMXY) Shares Gap Down – Here’s What Happened

Sysmex Corporation ADR (OTCMKTS:SSMXY) gapped down prior to trading on Friday . The stock had previously closed at $12.70, but opened at $12.28. Sysmex shares last traded at $12.28, with a volume of 9,761 shares trading hands.

Wall Street Analysts Forecast Growth

SSMXY has been the topic of several recent research reports. The Goldman Sachs Group raised Sysmex from a “hold” rating to a “buy” rating in a research report on Thursday. Zacks Research raised Sysmex from a “strong sell” rating to a “hold” rating in a research report on Thursday, August 14th. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy”.

Sysmex Stock Performance

The stock has a market capitalization of $7.62 billion, a P/E ratio of 24.23 and a beta of 1.16. The stock has a 50 day moving average of $13.07 and a 200 day moving average of $15.96. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.49 and a current ratio of 3.37.

Sysmex (OTCMKTS:SSMXY) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.07). Sysmex had a return on equity of 10.20% and a net margin of 9.35%.The business had revenue of $717.09 million during the quarter, compared to the consensus estimate of $807.27 million. Equities analysts predict that Sysmex Corporation ADR will post 0.57 EPS for the current year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.